Sir Ronnie Hampel, a towering figure in British industry, who served as chief executive and chairman of Imperial Chemical Industries (ICI) during a period of significant transformation, has died at the age of 93. His leadership was instrumental in the reshaping of ICI in the 1990s and the subsequent creation of the pharmaceutical giant Zeneca, now part of AstraZeneca. Hampel was widely regarded as a businessman's businessman, known for his sharp intellect and extensive network within the UK business establishment.

Born in Shrewsbury in 1932, Ronnie Hampel was the son of Karl Hampel, an Austrian engineer who had settled in Britain. He attended Canford school in Dorset, a challenging environment for children of German-speaking parents. Following national service in the Royal Horse Artillery, he pursued higher education at Corpus Christi College, Cambridge, where he studied modern languages and law. During his time at Cambridge, Hampel not only laid the groundwork for his formidable network of contacts but also earned a half-blue in tennis.

Hampel embarked on his distinguished career with ICI in 1955, a time when the company was considered a bellwether of British industry. He quickly gained experience across various divisions, eventually joining the emerging plant protection division in 1965. His career trajectory included a period in the United States, further broadening his international perspective and business acumen.

In 1977, Hampel was recalled to London to serve as general manager, commercial, a role designed to groom rising talent within the company. This position involved significant dealings with government ministers and departments, providing him with valuable experience in Whitehall. He was appointed chairman of the paints division in 1980, where his hands-on management style fostered staff engagement. His reputation for toughness, coupled with clear-minded intellectual challenge, grew as he took over ICI Agrochemicals in 1983 and was subsequently appointed to the main board of ICI in 1985.

As chairman of ICI from 1995 to 1999, Sir Ronnie oversaw a pivotal era for the company. He was a driving force behind the strategic decision to demerge ICI's pharmaceutical business, leading to the formation of Zeneca. This move proved prescient, as Zeneca evolved into a highly successful entity, now a core part of AstraZeneca. Under his leadership, ICI achieved record profits, including being the first British company to reach a £1 billion profit in 1985.

Beyond his corporate achievements, Sir Ronnie was known for his personal interests and connections. He married Jane Hewson in 1957, proposing just 24 hours after their first meeting; Jane maintained their home in Sussex throughout his varied career. An avid golfer, he achieved the rare distinction of becoming one of the first Britons outside the professional circuit to gain membership at the prestigious Augusta National club.

Sir Ronnie Hampel's legacy is marked by his profound impact on British industry, particularly his strategic vision in the pharmaceutical sector and his role in navigating ICI through a period of immense change. His career exemplified dedication, strategic foresight, and a deep understanding of both business and government relations, leaving an indelible mark on the corporate landscape.